Weekly Recap | Gilead Sciences -4.82%, most brokers rate it buyWeekly Review·Sep 12 at 08:16 AMGILD+0.65%
Weekly Recap | Illumina -5.39%, insider selling fuels valuation debateWeekly Review·Sep 12 at 06:07 AMILMN+3.63%
Weekly Recap | Corcept Therap -1.98%, most brokers rate it buyWeekly Review·Sep 5 at 06:29 AMCORT+0.77%
Weekly Recap | Neogenomics +6.3%, first-profit claim follows volume spikeWeekly Review·Aug 29 at 06:06 AMNEO+2.50%
